An evidence-based update on hepatic encephalopathy.

Area of Science:

• Hepatology
• Neurology
• Gastroenterology

Background:

• Hepatic encephalopathy (HE) is a central nervous system dysfunction linked to liver disease and porto-systemic shunting.
• It commonly occurs in advanced liver cirrhosis or acute liver failure, presenting with subtle to overt neuropsychiatric symptoms.
• Diagnosis often relies on clinical presentation after excluding other neurological causes, supported by various diagnostic tests.

Purpose of the Study:

• To review and critically analyze the current understanding and management strategies for hepatic encephalopathy.
• To emphasize the importance of early recognition, accurate diagnosis, and a multi-faceted treatment approach.

Main Methods:

• Comprehensive Medline search of relevant literature, including clinical trials and meta-analyses.
• Examination of all available guidelines and conference proceedings related to hepatic encephalopathy.
• Critical analysis of evidence for various management modalities.

Main Results:

• HE encompasses a spectrum of neuropsychiatric disturbances, from minimal HE to hepatic coma.
• Management involves supportive care, identifying and correcting precipitating factors (e.g., infection, constipation, drugs), and using medications to reduce toxin burden.
• Liver transplantation should be considered for all patients with HE.

Conclusions:

• Early recognition and accurate diagnosis are fundamental for appropriate HE management.
• A multi-target management plan, addressing contributing factors and employing specific therapies, is essential.
• Liver transplantation represents a definitive treatment option for eligible patients.